NLS Pharmaceutics, Kadimastem Sign MOU on Gene-Edited Therapies
The collaboration will progress under the combined company, NewCelX, upon completion of the anticipated merger ZURICH and NESSÂ ZIONA,…
Protein-based blood test detects early signs of ALS
September 16, 2025 At a Glance Researchers have found proteins in blood that accurately detect amyotrophic lateral sclerosis…